Yesterday, we reported that AMRI had purchased Hyaluron Contract Manufacturing (HCM), a privately held CMO focused on sterile filling of parenterals, with prefilled syringe capabilities. We contacted the company for more information about the $27 million deal and where AMRI plans to go from here. –GYR CP: How long was this acquisition in the works? AMRI: We have been performing market analysis and company specific analysis for over a year, with the Hyaluron acquisition representing t...